Home › Compare › ELEV vs ADC

ELEV vs ADC: Dividend Comparison 2026

ELEV yields 547.95% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELEV wins by $125545.37M in total portfolio value
10 years
ELEV
ELEV
● Live price
547.95%
Share price
$0.37
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$125545.55M
Annual income
$92,380,482,230.31
Full ELEV calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — ELEV vs ADC

📍 ELEV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELEVADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELEV + ADC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ELEV pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELEV
Annual income on $10K today (after 15% tax)
$46,575.34/yr
After 10yr DRIP, annual income (after tax)
$78,523,409,895.76/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, ELEV beats the other by $78,523,342,195.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELEV + ADC for your $10,000?

ELEV: 50%ADC: 50%
100% ADC50/50100% ELEV
Portfolio after 10yr
$62772.86M
Annual income
$46,190,280,938.77/yr
Blended yield
73.58%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

ELEV
Analyst Ratings
3
Buy
8
Hold
1
Sell
Consensus: Hold
Price Target
$9.00
+2365.8% upside vs current
Range: $8.00 — $10.00
Altman Z
-4.8
Piotroski
1/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELEV buys
0
ADC buys
7
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$ADC▼ Sell$15,001 - $50,0002026-01-15
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-08-13
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-06-17
Lisa McClain🏢 House$ADC▼ Sell$1,001 - $15,0002025-06-17
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-06-11
Lisa McClain🏢 House$ADC▲ Buy$1,001 - $15,0002025-06-11
Josh Gottheimer🏢 House$ADC▼ Sell$1,001 - $15,0002025-04-09
Josh Gottheimer🏢 House$ADC▲ Buy$1,001 - $15,0002024-04-15
Josh Gottheimer🏢 House$ADC▼ Sell$1,001 - $15,0002024-03-14
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELEVADC
Forward yield547.95% ✓4.11%
Annual dividend / share$2.00$3.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4% ✓
Portfolio after 10y$125545.55M ✓$176.9K
Annual income after 10y$92,380,482,230.31 ✓$79,647.25
Total dividends collected$122722.76M ✓$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$9.00$81.06 ✓

Year-by-year: ELEV vs ADC ($10,000, DRIP)

YearELEV PortfolioELEV Income/yrADC PortfolioADC Income/yrGap
1← crossover$65,495$54,794.52$10,987$577.21+$54.5K → ELEV
2$405,475$335,396.34$12,293$855.34+$393.2K → ELEV
3$2,374,450$1,940,591.70$14,088$1,290.70+$2.36M → ELEV
4$13,161,259$10,620,596.57$16,660$1,994.91+$13.14M → ELEV
5$69,099,868$55,017,321.36$20,525$3,181.85+$69.08M → ELEV
6$343,894,398$269,957,539.26$26,654$5,286.90+$343.87M → ELEV
7$1,623,590,885$1,255,623,879.22$37,006$9,259.47+$1623.55M → ELEV
8$7,277,465,834$5,540,223,587.11$55,862$17,338.74+$7277.41M → ELEV
9$30,995,389,120$23,208,500,677.65$93,452$35,300.32+$30995.30M → ELEV
10$125,545,548,589$92,380,482,230.31$176,931$79,647.25+$125545.37M → ELEV

ELEV vs ADC: Complete Analysis 2026

ELEV — Stock

Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced solid tumors harboring a neuregulin-1 fusion. Elevation Oncology, Inc. was incorporated in 2019 and is based in New York, New York.

Full ELEV Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this ELEV vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELEV vs SCHDELEV vs JEPIELEV vs OELEV vs KOELEV vs MAINELEV vs NNNELEV vs EPRTELEV vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.